The Potential Public Health and Community Impacts of Safer Injecting Facilities: Evidence From a Cohort of Injection Drug Users
- 1 January 2003
- journal article
- research article
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 32 (1) , 2-8
- https://doi.org/10.1097/00126334-200301010-00002
Abstract
Although medically supervised safer injecting facilities (SIFs) remain untested in North America, their implementation is currently being debated. Reluctance of health policy makers to initiate a pilot study of SIFs may in part be hindered by outstanding questions regarding the potential community and public health impact of the intervention. Specifically, it is presently unknown if those at greatest risk of overdose and HIV transmission or those responsible for community impact of injection drug use will be willing to attend. The current study was conducted to evaluate the proportion of injection drug users (IDU) willing to attend medically supervised SIFs, if they were available, among participants enrolled in the Vancouver Injection Drug User Study (VIDUS). The authors also evaluated factors associated with willingness to use a SIF using univariate and logistic regression analyses. Participants who were followed from June 2001 to June 2002 were eligible for the present analyses. Overall, 587 active IDU responded to a questionnaire during the study period. Among respondents, 215 (36.6%) expressed willingness to attend a SIF. Variables that were independently associated with willingness to attend a SIF in multivariate analyses included having difficulty accessing sterile syringes (adjusted odds ratio [AOR] = 2.07), requiring help injecting (AOR = 1.52), frequently injecting heroin (AOR = 1.81), sex trade work (AOR = 2.02), and injecting in public spaces (AOR = 2.00). Several variables that have recently been associated with overdose, syringe sharing, HIV and HCV incidence, and community impact of illicit drug use in this setting were associated with willingness to attend medically supervised SIFs. Although the impact of SIFs in North America can only be quantified by scientific evaluation, these data indicate a high potential for immediate community and public health benefits if SIFs were presently available.Keywords
This publication has 19 references indexed in Scilit:
- Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programmeAIDS, 2002
- Sex Differences in Risk Factors for HIV Seroconversion Among Injection Drug UsersArchives of internal medicine (1960), 2001
- Fatal Overdose Trends in Major us Cities: 1990–1997Addiction Research & Theory, 2001
- Preference to have used a medically supervised injecting centre among injecting drug users in Kings Cross, SydneyAustralian and New Zealand Journal of Public Health, 2000
- Drug consumption facilities in Europe and the establishment of supervised injecting centres in AustraliaDrug and Alcohol Review, 2000
- Antiretroviral medication use among injection drug users: two potential futuresAIDS, 2000
- The professional acceptance of drug use: a closer look at drug consumption rooms in the Netherlands, Germany and SwitzerlandInternational Journal of Drug Policy, 1999
- Needle exchange is not enoughAIDS, 1997
- HIV incidence among injecting drug users in New York City syringe-exchange programmesThe Lancet, 1996
- Evaluation der Gassenzimmer I, II und III in BaselInternational Journal of Public Health, 1996